(Q43925629)

28 November 2017

title

Ketoconazole increases cocaine and opioid use in methadone maintained patients (English)

1 reference

28 November 2017

0 references

Thomas R Kosten

1

1 reference

28 November 2017

Alison Oliveto

2

1 reference

28 November 2017

Kevin A Sevarino

3

1 reference

28 November 2017

Kishor Gonsai

4

1 reference

28 November 2017

Alan Feingold

5

1 reference

28 November 2017

publication date

1 April 2002

1 reference

Drug and Alcohol Dependence

28 November 2017

published in

1 reference

28 November 2017

volume

66

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

173-180

1 reference

Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

The effect of fluconazole on the clinical pharmacokinetics of methadone

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

A neuroendocrine role in cocaine reinforcement

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of intravenous cocaine self-administration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Ketoconazole reduces low dose cocaine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Substance use disorders in patients with posttraumatic stress disorder: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped?

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Beta endorphin levels during heroin, methadone, buprenorphine, and naloxone challenges: preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Methadone dosages and therapeutic compliance during a methadone maintenance program

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

The Fifth Edition of the Addiction Severity Index

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Cocaine effects on pulsatile secretion of anterior pituitary, gonadal, and adrenal hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Corticosterone levels determine individual vulnerability to amphetamine self-administration

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Inhibition of corticosterone synthesis by Metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Antiglucocorticoids as Treatments for Depression : Rationale for Use and Therapeutic Potential

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

The use of ketoconazole as an inhibitor of steroid production

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Dose-response effects of methadone in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Ketoconazole attenuates the cortisol response but not the subjective effects of smoked cocaine in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

Ketoconazole administration in hypercortisolemic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900198-3

7 January 2021

10.1016/S0376-8716(01)00198-3

Identifiers

DOI

1 reference

28 November 2017

1 reference